Industry News
Over Two Thirds Of Sunbed Users Concerned They Are Aging Their Skin
Feb 23, 2013
Results of a survey by the charity Cancer Research UK show that more than two thirds (68%) of people who use sunbeds are concerned that the practice is aging their skin. The research, which polled 2,500 UK adults in January, was released to coincide with the charity's R UV UGLY sunbed awareness campaign... Read More
Kadcyla For Late-Stage Breast Cancer Approved By FDA
Feb 22, 2013
Kadcyla (ado-trastuzumab emtansine), a new medication for the treatment of HER2-positive, metastatic breast cancer, has been approved by the Food and Drug Administration (FDA), USA. Metastatic, also known as late-stage, means the cancer has spread to other parts of the body... Read More
Kadcyla For Late-Stage Breast Cancer Approved By FDA
Feb 22, 2013
Kadcyla (ado-trastuzumab emtansine), a new medication for the treatment of HER2-positive, metastatic breast cancer, has been approved by the Food and Drug Administration (FDA), USA. Metastatic, also known as late-stage, means the cancer has spread to other parts of the body... Read More
Astronomy Algorithms Help Diagnose Aggressive Tumors
Feb 22, 2013
In a remarkable example of interdisciplinary teamwork, astronomers are helping cancer researchers use computerized stargazing algorithms developed for spotting distant galaxies to identify biomarkers in tumors to determine how aggressive they are... Read More
Astronomy Algorithms Help Diagnose Aggressive Tumors
Feb 22, 2013
In a remarkable example of interdisciplinary teamwork, astronomers are helping cancer researchers use computerized stargazing algorithms developed for spotting distant galaxies to identify biomarkers in tumors to determine how aggressive they are... Read More
Bendamustine (Levact®) Plus Rituximab More Effective Than CHOP-R In Treating Patients With Indolent Non-Hodgkin Lymphoma And Mantle Cell Lymphoma
Feb 22, 2013
Treatment with bendamustine plus rituximab (B-R) doubles progression free survival (PFS) compared with current standard of care CHOP-R (69.5 versus 31... Read More
Bendamustine (Levact®) Plus Rituximab More Effective Than CHOP-R In Treating Patients With Indolent Non-Hodgkin Lymphoma And Mantle Cell Lymphoma
Feb 22, 2013
Treatment with bendamustine plus rituximab (B-R) doubles progression free survival (PFS) compared with current standard of care CHOP-R (69.5 versus 31... Read More
For Colorectal Cancer Prevention, Resistant Starch Should Be On The Menu
Feb 22, 2013
As the name suggests, you can't digest resistant starch so it ends up in the bowel in pretty much the same form it entered your mouth. As unlovely as that seems, once in the bowel this resistant starch does some important things, including decreasing bowel pH and transit time, and increasing the production of short-chain fatty acids... Read More
Promising New Compound For Battling Kidney Cancer
Feb 22, 2013
Chemists at the University of California, Riverside have developed a compound that holds much promise in the laboratory in fighting renal (kidney) cancer... Read More
New Silicone Gel-Filled Breast Implant Approved by FDA
Feb 22, 2013
A new breast implant called the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant to increase breast size in females 22 and older and to rebuild breast tissue of women of all ages, has been approved by the US FDA. The Natrelle 410 implants are manufactured by Allergan, Inc... Read More
Previous Page Next Page